Skip to main content
. 2022 Aug 30;10(9):1428. doi: 10.3390/vaccines10091428

Figure 3.

Figure 3

Safety profile of nanoparticles in shrimp. Shrimp were injected with 500 mg of either 20:80 CPTEG:CPH or 20:80 CPH:SA nanoparticles by reverse gavage (RG). (A) Shrimp survival was monitored through 60 days postinjection. Data are expressed as the mean ± SEM of three independent experiments. No statistical difference between groups at day 60. (B) Blinded histopathological analysis of tissue was performed by fixing live shrimp in Davidson’s fixative. Scale bar = 20 mm.